Fast targeted multidimensional NMR metabolomics of colorectal cancer
暂无分享,去创建一个
M R Viant | U. Günther | C. Ludwig | M. Viant | D. Ward | T. Ismail | A. Martín | C Ludwig | D G Ward | A Martin | T Ismail | P J Johnson | M J O Wakelam | U L Günther | P. Johnson | M. Wakelam | A. Martín
[1] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[2] Ian D. Wilson,et al. HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .
[3] S. Moss,et al. RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER Results for First 107 349 Subjects , 1989, The Lancet.
[4] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[5] A. J. Shaka,et al. Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients , 1995 .
[6] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[7] F Baganz,et al. Systematic functional analysis of the yeast genome. , 1998, Trends in biotechnology.
[8] Ludwig,et al. NMRLAB-Advanced NMR data processing in matlab , 2000, Journal of magnetic resonance.
[9] S. Thibodeau,et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.
[10] John C. Lindon,et al. Pattern recognition methods and applications in biomedical magnetic resonance , 2001 .
[11] D. Kell,et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations , 2001, Nature Biotechnology.
[12] S. Goodman,et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. , 2001, Journal of the National Cancer Institute.
[13] J. Nicholson,et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.
[14] Julian L Griffin,et al. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. , 2003, Current opinion in chemical biology.
[15] R. Freeman,et al. Hadamard NMR Spectroscopy , 2003 .
[16] George G Harrigan,et al. Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP). , 2003, Current cancer drug targets.
[17] E. Eigenbrodt,et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer , 2004, British Journal of Cancer.
[18] Jan van der Greef,et al. Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis. , 2004, International immunopharmacology.
[19] Daniel Raftery,et al. Use of semiselective TOCSY and the pearson correlation for the metabonomic analysis of biofluid mixtures: application to urine. , 2005, Analytical chemistry.
[20] George G Harrigan,et al. Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. , 2005, Mini reviews in medicinal chemistry.
[21] Daniel Raftery,et al. Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: application to the metabonomics of amino acids in honey. , 2005, Analytical chemistry.
[22] I. Wilson,et al. Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.
[23] D. Ward,et al. Identification of serum biomarkers for colon cancer by proteomic analysis , 2006, British Journal of Cancer.
[24] Julian L Griffin,et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease , 2006, Nature Medicine.
[25] O. Fiehn,et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. , 2006, Cancer research.
[26] T. Ebbels,et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.
[27] Gerhard Wagner,et al. Ultrahigh-resolution (1)H-(13)C HSQC spectra of metabolite mixtures using nonlinear sampling and forward maximum entropy reconstruction. , 2007, Journal of the American Chemical Society.
[28] Tariq Ismail,et al. Proteomic profiling of urine for the detection of colon cancer , 2008, Proteome Science.
[29] Mark R Viant,et al. Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. , 2008, Analytical biochemistry.
[30] Stefano Tiziani,et al. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. , 2009, Neoplasia.
[31] Rachel Cavill,et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.
[32] Mark R Viant,et al. International NMR-based environmental metabolomics intercomparison exercise. , 2009, Environmental science & technology.